Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study

• DOI: 10.18087/cardio.2021.4.n1628
• Publication Date: 2021-05-17T11:35:40Z
• Authors: D. S. Polyakov; I. V. Fomin; Yu. N. Belenkov; V. Yu. Mareev; F. T. Ageev; E. G. Artemjeva; Yu. V. Badin; E. V. Bakulina; N. G. Vinogradova; A. S. Galyavich; T. S. Ionova; G. M. Kamalov; S. G. Kechedzhieva; N. A. Koziolova; V. Yu. Malenkova; S. V. Malchikova; Yu. V. Mareev; E. A. Smirnova; E. I. Tarlovskaya; E. V. Shcherbinina; S. S. Yakushin
• Keywords: Etiology

Aim To study the etiology and dynamics of prevalence mortality CHF; to evaluate treatment coverage such patients in a representative sample European part Russian Federation for 20-year period. Material methods A followed up 2002 through 2017 (n=19 276); population Nizhny Novgorod region examined 1998 (n=1922). Results During observation period since 2002, incidence major CHF symptoms (tachycardia, edema, shortness breath, weakness) tended decrease while cardiovascular diseases has statistically significantly increased. from 2017, I-IV functional class (FC) increased 6.1 % 8.2 whereas III-IV FC 1.8 3.1 %. The main causes development remained arterial hypertension ischemic heart disease; role myocardial infarction diabetes mellitus as was noted. For analyzed period, number components basic therapy with increased, which probably accounts slower increase disease by 2007–2017. prognosis unfavorable: I-II CHF, median survival 8.4 (95 CI: 7.8–9.1) years 3.8 3.4–4.2) years.